These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Bone scintigraphy in pleural metastases of osteogenic sarcoma. Palestro CJ; Styles ST; Kim CK; Goldsmith SJ Clin Nucl Med; 1990 May; 15(5):346-7. PubMed ID: 2340679 [No Abstract] [Full Text] [Related]
27. The indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients. McKillop JH; Etcubanas E; Goris ML Cancer; 1981 Sep; 48(5):1133-8. PubMed ID: 6268278 [TBL] [Abstract][Full Text] [Related]
28. The role of bone scintigraphy in osteogenic sarcoma. Rees CR; Siddiqui AR; duCret R Skeletal Radiol; 1986; 15(5):365-7. PubMed ID: 3090705 [TBL] [Abstract][Full Text] [Related]
29. Gallium-67 and technetium-99m-methylene diphosphonate skeletal scintigraphy in determining prognosis for children with stage IV neuroblastoma. Macdonald WB; Stevens MM; Dalla Pozza L; Bergin M; Menser MA; Howman-Giles R; Uren RF J Nucl Med; 1993 Jul; 34(7):1082-6. PubMed ID: 8315482 [TBL] [Abstract][Full Text] [Related]
30. Relevance of the POS-1 orthotopic model as an "imaging model" for in vivo and simultaneous monitoring of tumor proliferation and bone remodeling in osteosarcoma. Miot-Noirault E; Gouin F; Dauplat MM; Heymann D; Chezal JM; Redini F Cancer Biother Radiopharm; 2012 Feb; 27(1):96-103. PubMed ID: 22217151 [TBL] [Abstract][Full Text] [Related]
31. Technetium-99 m-MDP scintigraphy and long-term follow-up of musculo-skeletal sarcoma reconstructed with pasteurized autologous bone graft. Ahmed AR Arch Orthop Trauma Surg; 2009 Apr; 129(4):475-82. PubMed ID: 18506456 [TBL] [Abstract][Full Text] [Related]
32. Impact of abnormal uptakes in bone scan on the prognosis of patients with lung cancer. Park JY; Kim KY; Lee J; Kam S; Son JW; Kim CH; Jung TH Lung Cancer; 2000 Apr; 28(1):55-62. PubMed ID: 10704710 [TBL] [Abstract][Full Text] [Related]
33. Tc-99m MDP bone scintigraphy in a patient with multicentric osteosarcoma. Cermik TF; Salan A; Firat MF; Berkarda S Clin Nucl Med; 2003 Jul; 28(7):599-600. PubMed ID: 12819421 [No Abstract] [Full Text] [Related]
34. Changing indications for bone scintigraphy in patients with osteosarcoma. Goldstein H; McNeil BJ; Zufall E; Jaffe N; Treves S Radiology; 1980 Apr; 135(1):177-80. PubMed ID: 6928698 [TBL] [Abstract][Full Text] [Related]
36. Relationship between quantitative tumor scintigraphy and time to metastasis in dogs with osteosarcoma. Forrest LJ; Dodge RK; Page RL; Heidner GL; McEntee MC; Novotney CA; Thrall DE J Nucl Med; 1992 Aug; 33(8):1542-7. PubMed ID: 1634948 [TBL] [Abstract][Full Text] [Related]
37. The value of pretreatment clinical and biochemical parameters in staging and prognostic stratification of patients with newly diagnosed prostate carcinoma. Stokkel MP; Zwinderman AH; Zwartendijk J; Pauwels EK; Van Eck-Smit BL Int J Biol Markers; 1998; 13(2):70-6. PubMed ID: 9803354 [TBL] [Abstract][Full Text] [Related]
38. The role of bone scintigraphy in the follow-up of osteogenic sarcoma. Körholz D; Wirtz I; Vosberg H; Rüther W; Jürgens H; Göbel U Eur J Cancer; 1996 Mar; 32A(3):461-4. PubMed ID: 8814693 [TBL] [Abstract][Full Text] [Related]
39. The role of 99mTc(V)-DMSA scan as compared to 99mTc-MDP and CT scans in imaging the primary tumor and metastases of osteosarcoma. Zissimopoulos A; Zanglis A; Andreopoulos D; Baziotis N Hell J Nucl Med; 2005; 8(3):162-4. PubMed ID: 16390022 [TBL] [Abstract][Full Text] [Related]
40. [The problem of false positives in bone scintigraphy in patients with breast neoplasms. A follow-up at 10 years]. Campostrini F; Di Marco A; Micciolo R; Grandinetti A; Griso C; Palazzi M; Zamboni M Radiol Med; 1990 May; 79(5):539-43. PubMed ID: 2113699 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]